| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84f4e307c3d530a910727cc7c7ec1daa |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-0017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-065 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L2-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-06 |
| filingDate |
2002-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6cbe42efc41b60601c92136f1701928b |
| publicationDate |
2002-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-02076502-A1 |
| titleOfInvention |
Human medical treatment by application of immunoglobulin a |
| abstract |
Pooled human plasma is processed by cold ethanol fractionation to produce purified immunoglobulin G antibodies for intravenous administration. Immunoglobulin A is an unwanted by-product since intravenous administration of immunoglobulin A-containing immunoglobulin G can cause life-threatening anaphylaxis in some people. The present invention is the topical application of immunoglobulin A coupled with recombinant J chain, and optionally coupled with recombinant secretory component in order to render the immunoglobulin A more physiologically active, for the prevention or treatment of ocular diseases including ocular immune deficiency and infections. Antigen-specific monoclonal immunoglobulin A may be used. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102142261-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9932392-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2636682-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10385117-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2013201393-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013132052-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9828418-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104254542-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20140132770-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111116735-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10221233-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015510875-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013174971-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3907238-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2013265203-B2 |
| priorityDate |
2001-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |